CEP55 and breast cancer: Evidence presented here shows this is likely because it promotes genomic instability and resistance to anti‐mitotic drugs—even partial knockdown of CEP55 was sufficient for aneuploid breast cancer cell elimination in vitro (Figs 2, 3, 4).